Insider Buying: Oscar Health, Inc. (NYSE:OSCR) Director Buys 420,819 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the acquisition, the director now directly owns 5,452,081 shares of the company’s stock, valued at approximately $74,584,468.08. The trade was a 8.36 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Oscar Health Price Performance

OSCR opened at $15.45 on Friday. Oscar Health, Inc. has a 52-week low of $6.93 and a 52-week high of $23.79. The company has a 50 day moving average of $18.28 and a two-hundred day moving average of $18.30. The company has a market cap of $3.74 billion, a P/E ratio of -251.12, a P/E/G ratio of 12.49 and a beta of 1.67. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same period last year, the business earned ($0.29) earnings per share. On average, analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Versor Investments LP purchased a new stake in shares of Oscar Health during the third quarter valued at approximately $787,000. Assenagon Asset Management S.A. increased its stake in Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after buying an additional 507,009 shares during the period. FCG Investment Co acquired a new position in Oscar Health in the 3rd quarter worth $986,000. Jupiter Asset Management Ltd. purchased a new position in Oscar Health in the 1st quarter valued at about $653,000. Finally, Toth Financial Advisory Corp increased its position in shares of Oscar Health by 73,185.7% during the third quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company’s stock worth $1,088,000 after acquiring an additional 51,230 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on OSCR shares. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Piper Sandler reissued an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target for the company. One analyst has rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.